|
May 2
|
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
|
|
May 2
|
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
|
|
May 2
|
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
|
|
May 2
|
Amgen, DraftKings, Live Nation: Trending tickers
|
|
May 2
|
UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
|
|
May 2
|
Amgen Surges On Strong First-Quarter Profit As Obesity Space Heats Up
|
|
May 2
|
Amgen 'encouraged' by weight-loss drug interim data, shares jump
|
|
May 2
|
AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
|
|
May 1
|
Amgen investors await weight-loss drug data
|
|
May 1
|
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
|
|
Apr 30
|
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
|
|
Apr 30
|
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
|
|
Apr 30
|
Sandoz reaches agreement with Amgen over patent dispute
|
|
Apr 29
|
AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS
|
|
Apr 29
|
What's in the Cards for Amgen (AMGN) This Earnings Season?
|
|
Apr 29
|
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
|
|
Apr 26
|
A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed
|
|
Apr 26
|
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
|
|
Apr 25
|
20 Fastest Growing Health Tech Companies in the World
|
|
Apr 25
|
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
|